Latest Transformation News

Xamble Group reports a revenue rebound to A$1.7 million in Q3 2025 alongside narrowing EBITDA losses, reflecting early gains from its transformation strategy and technology investments.

Riedel Resources has contracted Energold Drilling Corp to undertake a 1,100m diamond drilling campaign at its Kingman Gold Project in Arizona, aiming to extend high-grade gold and silver mineralisation and support metallurgical testing.

Senetas Corporation has streamlined its operations following the sale of Votiro, reporting a strong financial position and unveiling plans for a significant capital return and share consolidation.

Tivan Limited has revealed promising high-grade copper and gold mineralisation from its maiden surface sampling at the Turiscai Project, marking a significant step in its Timor-Leste exploration strategy.

Biotron Limited’s lead HBV drug BIT-HBV001 demonstrates superior antiviral activity and synergy with the current standard treatment Tenofovir in preclinical models, advancing hopes for a more effective Hepatitis B therapy.

Acrow Limited reported a 4% rise in underlying net profit for FY25, driven by strategic acquisitions and a growing industrial access division now contributing half of group revenue. Despite some formwork delays, the company maintains a strong project pipeline and steady dividends.

Trigg Minerals has expanded its Tennessee Mountain Tungsten Project in Nevada by acquiring contiguous claims that consolidate a district-scale mineralised system, setting the stage for modern exploration and resource definition.

Vulcan Energy has appointed ABB as the main electrical contractor for its flagship Lionheart lithium project, marking a significant step towards financing and construction. The €46 million fixed-price contract covers comprehensive electrical infrastructure for a facility set to produce enough lithium for 500,000 electric vehicles annually.

PYC Therapeutics reports sustained vision improvements in patients with Retinitis Pigmentosa type 11 treated with VP-001, showing promising safety and efficacy up to 18 months. The company plans to engage the FDA in early 2026 to finalize pivotal trial design.

Alkane Resources reports a strong first quarter for FY2026, driven by its recent acquisition of Mandalay Resources, boosting gold equivalent production and revenue significantly.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

Tombador Iron Limited has completed its strategic acquisition of GoviEx Uranium Inc., paving the way for a relisting as Atomic Eagle Ltd focused on uranium exploration.